Cargando…

Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein

α‐Synuclein oligomers are thought to have a pivotal role in sporadic and familial Parkinson's disease (PD) and related α‐synucleinopathies, causing dysregulation of protein trafficking, autophagy/lysosomal function, and protein clearance, as well as synaptic function impairment underlying motor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Limegrover, Colleen S., Yurko, Raymond, Izzo, Nicholas J., LaBarbera, Kelsie M., Rehak, Courtney, Look, Gary, Rishton, Gilbert, Safferstein, Hank, Catalano, Susan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986605/ https://www.ncbi.nlm.nih.gov/pubmed/33480104 http://dx.doi.org/10.1002/jnr.24782

Ejemplares similares

Alzheimer’s protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity
por: Limegrover, Colleen S., et al.
Publicado: (2020)

Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery
por: LaBarbera, Kelsie Mozzoni, et al.
Publicado: (2021)

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
por: Izzo, Nicholas J., et al.
Publicado: (2014)

Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification
por: Izzo, Nicholas J., et al.
Publicado: (2021)

A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease
por: Grundman, Michael, et al.
Publicado: (2019)

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits
por: Izzo, Nicholas J., et al.
Publicado: (2014)

A small molecule toll-like receptor antagonist rescues α-synuclein fibril pathology
por: Chedid, Jessica, et al.
Publicado: (2022)

Motor and Nonmotor Symptoms of Parkinson's Disease: Antagonistic Pleiotropy Phenomena Derived from α-Synuclein Evolvability?
por: Takamatsu, Yoshiki, et al.
Publicado: (2018)

A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter
por: LaBarbera, Kelsie M., et al.
Publicado: (2023)

Occipital intermittent rhythmic delta activity (OIRDA) in pediatric focal epilepsies: A case series
por: LaBarbera, Vincent, et al.
Publicado: (2021)

The Bcl-2 homologue Buffy rescues α-synuclein-induced Parkinson disease-like phenotypes in Drosophila
por: M’Angale, P. Githure, et al.
Publicado: (2016)

Cerium Oxide Nanoparticles Rescue α-Synuclein-Induced Toxicity in a Yeast Model of Parkinson’s Disease
por: Ruotolo, Roberta, et al.
Publicado: (2020)

Invasive aspergillosis in an immunocompetent patient with fever and a cardiac mass
por: LaBarbera, Matthew, et al.
Publicado: (2011)

β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins
por: Ninkina, Natalia, et al.
Publicado: (2021)

GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
por: Schneider, Jay S., et al.
Publicado: (2019)

Applying six sigma using Minitab /
por: Bruce, Gilbert
Publicado: (2019)

The histamine H3 receptor antagonist thioperamide rescues circadian rhythm and memory function in experimental parkinsonism
por: Masini, D, et al.
Publicado: (2017)

Optogenetic Rescue of Locomotor Dysfunction and Dopaminergic Degeneration Caused by Alpha-Synuclein and EKO Genes
por: Qi, Cheng, et al.
Publicado: (2017)

Hsc70 rescues the synaptic vesicle trafficking defects caused by α-synuclein dimers
por: Brady, Emily B., et al.
Publicado: (2023)

Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson’s disease
por: Melo, T. Q., et al.
Publicado: (2016)

Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson’s disease model
por: Wegrzynowicz, Michal, et al.
Publicado: (2019)

Sigma 1 Receptor Antagonists Inhibit Manic-Like Behaviors in Two Congenital Strains of Mice
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2018)

Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression
por: Wang, Yong, et al.
Publicado: (2020)

Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synuclein
por: Chung, Eunna, et al.
Publicado: (2020)

CSPα reduces aggregates and rescues striatal dopamine release in α-synuclein transgenic mice
por: Caló, Laura, et al.
Publicado: (2021)

Therapeutic Potential of α-Synuclein Evolvability for Autosomal Recessive Parkinson's Disease
por: Wei, Jianshe, et al.
Publicado: (2021)

On the width of SIGMA hypernuclei and SIGMA- atoms
por: Brockmann, R, et al.
Publicado: (1982)

Sum rules for $\SIGMA\SIGMA$ (In Russian)
por: Fil'kov, L V, et al.
Publicado: (1970)

Rescue of Transgenic Alzheimer’s Pathophysiology by Polymeric Cellular Prion Protein Antagonists
por: Gunther, Erik C., et al.
Publicado: (2019)

Sigma-1 receptor chaperones rescue nucleocytoplasmic transport deficit seen in cellular and Drosophila ALS/FTD models
por: Lee, Pin-Tse, et al.
Publicado: (2020)

Similarity of the non-amyloid-β component and C-terminal tail of monomeric and tetrameric alpha-synuclein with 14-3-3 sigma
por: Evans, Sarah R., et al.
Publicado: (2021)

The sigma receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking
por: Sabino, Valentina, et al.
Publicado: (2008)

The selective sigma-1 receptor antagonist E-52862 attenuates neuropathic pain of different aetiology in rats
por: Gris, Georgia, et al.
Publicado: (2016)

$\Sigma^{+}$, $\Sigma^{0}$ and $\Sigma^{-}$ hyperon production in hadronic $Z^{0}$ decays
por: Alexander, Gideon, et al.
Publicado: (1996)

Is the nonlinear sigma model the m$_{sigma}$ --> $\infty$ limit of the linear sigma model?
por: Chan, L H
Publicado: (1987)

Sigma+, Sigma0 and Sigma- Hyperon Production in Hadronic Z0- Decays
por: CERN. Geneva
Publicado: (1995)

Rapid Evolution of Virus Sequences in Intrinsically Disordered Protein Regions
por: Gitlin, Leonid, et al.
Publicado: (2014)

Central Disorders of Hypersomnolence, Restless Legs Syndrome, and Surgery With General Anesthesia: Patient Perceptions
por: LaBarbera, Vincent, et al.
Publicado: (2018)

Ecological and demographic impacts of a recent volcanic eruption on two endemic patagonian rodents
por: Lacey, Eileen A., et al.
Publicado: (2019)

Caloric restriction rescues yeast cells from alpha-synuclein toxicity through autophagic control of proteostasis
por: Sampaio-Marques, Belém, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3jh3kultf34m5acp8en0cv5nhp